Nasopharyngeal pneumococcal carriage in Indian children following 10-valent PCV (PNEUMOSIL®) introduction through India's universal immunization program: A post licensure cross-sectional study.

V. Sethna, A. Apte, S. Sanghavi, Y. Tang, C. Poonawalla, R. Dhere, G. Dayma, A. Kawade, R. Nerlekar, A. Jadhav, R. Tuttle, W.P. Hausdorff, A. Bavdekar

Open source

DOI
10.1016/j.vaccine.2025.128129
Published
2026-02
Container
Vaccine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.vaccine.2025.128129,
  title = {Nasopharyngeal pneumococcal carriage in Indian children following 10-valent PCV (PNEUMOSIL®) introduction through India's universal immunization program: A post licensure cross-sectional study.},
  author = {V. Sethna and A. Apte and S. Sanghavi and Y. Tang and C. Poonawalla and R. Dhere and G. Dayma and A. Kawade and R. Nerlekar and A. Jadhav and R. Tuttle and W.P. Hausdorff and A. Bavdekar},
  year = {2026},
  journal = {Vaccine},
  doi = {10.1016/j.vaccine.2025.128129},
  url = {https://doi.org/10.1016/j.vaccine.2025.128129}
}

RIS

TY  - JOUR
TI  - Nasopharyngeal pneumococcal carriage in Indian children following 10-valent PCV (PNEUMOSIL®) introduction through India's universal immunization program: A post licensure cross-sectional study.
AU  - V. Sethna
AU  - A. Apte
AU  - S. Sanghavi
AU  - Y. Tang
AU  - C. Poonawalla
AU  - R. Dhere
AU  - G. Dayma
AU  - A. Kawade
AU  - R. Nerlekar
AU  - A. Jadhav
AU  - R. Tuttle
AU  - W.P. Hausdorff
AU  - A. Bavdekar
PY  - 2026
JO  - Vaccine
DO  - 10.1016/j.vaccine.2025.128129
UR  - https://doi.org/10.1016/j.vaccine.2025.128129
ER  - 

APA

Sethna, V., Apte, A., Sanghavi, S., Tang, Y., Poonawalla, C., Dhere, R., Dayma, G., Kawade, A., Nerlekar, R., Jadhav, A., Tuttle, R., Hausdorff, W., & Bavdekar, A. (2026). Nasopharyngeal pneumococcal carriage in Indian children following 10-valent PCV (PNEUMOSIL®) introduction through India's universal immunization program: A post licensure cross-sectional study.. Vaccine. https://doi.org/10.1016/j.vaccine.2025.128129

Source records